BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
+66.94%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$2.27B
AUM Growth
+$2.27B
Cap. Flow
+$37.2M
Cap. Flow %
1.63%
Top 10 Hldgs %
52.32%
Holding
69
New
7
Increased
11
Reduced
6
Closed
3

Top Buys

1
PRNB
Principia Biopharma Inc. Common Stock
PRNB
$36.3M
2
AMRN
Amarin Corp
AMRN
$32.9M
3
RNA icon
Avidity Biosciences
RNA
$31.7M
4
SNDX icon
Syndax Pharmaceuticals
SNDX
$23.1M
5
IDYA icon
IDEAYA Biosciences
IDYA
$20.4M

Top Sells

1
REGN icon
Regeneron Pharmaceuticals
REGN
$65.9M
2
IMMU
Immunomedics Inc
IMMU
$65.4M
3
RCUS icon
Arcus Biosciences
RCUS
$24.7M
4
SAGE
Sage Therapeutics
SAGE
$18.2M
5
AXSM icon
Axsome Therapeutics
AXSM
$8.83M

Sector Composition

1 Healthcare 85.93%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
IMMU
1
DELISTED
Immunomedics Inc
IMMU
$234M 10.29% 6,606,000 -1,844,000 -22% -$65.4M
MRTX
2
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$202M 8.86% 1,765,560 – –
ONC
3
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$174M 7.66% 925,000 – –
ODT
4
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$142M 6.26% 3,363,377 – –
RVMD icon
5
Revolution Medicines
RVMD
$7.1B
$93.4M 4.11% 2,959,264 -90,500 -3% -$2.86M
SWTX
6
DELISTED
SpringWorks Therapeutics
SWTX
$87.2M 3.83% 2,075,905 – –
BDTX icon
7
Black Diamond Therapeutics
BDTX
$157M
$84.9M 3.73% 2,014,858 – –
SGEN
8
DELISTED
Seagen Inc. Common Stock
SGEN
$68M 2.99% 400,000 – –
PASG icon
9
Passage Bio
PASG
$22.7M
$52.7M 2.32% 1,928,315 +45,000 +2% +$1.23M
RCUS icon
10
Arcus Biosciences
RCUS
$1.13B
$51.6M 2.27% 2,084,883 -1,000,000 -32% -$24.7M
ESPR icon
11
Esperion Therapeutics
ESPR
$448M
$50M 2.2% 975,000 – –
ALLK
12
DELISTED
Allakos
ALLK
$48.5M 2.13% 675,000 – –
AMRN
13
Amarin Corp
AMRN
$311M
$48.4M 2.13% 7,000,000 +4,750,000 +211% +$32.9M
SAGE
14
DELISTED
Sage Therapeutics
SAGE
$45.5M 2% 1,094,000 -438,510 -29% -$18.2M
ARGX icon
15
argenx
ARGX
$43.6B
$38.5M 1.69% 170,926 -29,074 -15% -$6.55M
BCEL
16
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$36.9M 1.62% 1,733,583 – –
PRNB
17
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$36.3M 1.6% +607,000 New +$36.3M
CGEN icon
18
Compugen
CGEN
$132M
$35.8M 1.57% 2,383,673 – –
FOLD icon
19
Amicus Therapeutics
FOLD
$2.34B
$35.1M 1.54% 2,325,000 – –
QURE icon
20
uniQure
QURE
$896M
$34.5M 1.52% 765,400 – –
SNDX icon
21
Syndax Pharmaceuticals
SNDX
$1.41B
$33.9M 1.49% 2,287,782 +1,562,000 +215% +$23.1M
GOSS icon
22
Gossamer Bio
GOSS
$562M
$33.3M 1.46% 2,562,358 +377,358 +17% +$4.91M
TRIL
23
DELISTED
Trillium Therapeutics Inc.
TRIL
$33M 1.45% 4,075,000 – –
KDMN
24
DELISTED
Kadmon Holdings, Inc.
KDMN
$31.8M 1.4% 6,205,882 – –
RNA icon
25
Avidity Biosciences
RNA
$5.99B
$31.7M 1.39% +1,121,327 New +$31.7M
1
2 3